Correlation Between Cancer Genetics and Oppenheimer Ultra

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cancer Genetics and Oppenheimer Ultra at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cancer Genetics and Oppenheimer Ultra into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cancer Genetics and Oppenheimer Ultra Short Duration, you can compare the effects of market volatilities on Cancer Genetics and Oppenheimer Ultra and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cancer Genetics with a short position of Oppenheimer Ultra. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cancer Genetics and Oppenheimer Ultra.

Diversification Opportunities for Cancer Genetics and Oppenheimer Ultra

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cancer and Oppenheimer is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cancer Genetics and Oppenheimer Ultra-Short Durati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oppenheimer Ultra-short and Cancer Genetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cancer Genetics are associated (or correlated) with Oppenheimer Ultra. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oppenheimer Ultra-short has no effect on the direction of Cancer Genetics i.e., Cancer Genetics and Oppenheimer Ultra go up and down completely randomly.

Pair Corralation between Cancer Genetics and Oppenheimer Ultra

If you would invest (100.00) in Oppenheimer Ultra Short Duration on December 30, 2023 and sell it today you would earn a total of  100.00  from holding Oppenheimer Ultra Short Duration or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cancer Genetics  vs.  Oppenheimer Ultra-Short Durati

 Performance 
       Timeline  
Cancer Genetics 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Cancer Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong forward indicators, Cancer Genetics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.
Oppenheimer Ultra-short 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Oppenheimer Ultra Short Duration has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Oppenheimer Ultra is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Cancer Genetics and Oppenheimer Ultra Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cancer Genetics and Oppenheimer Ultra

The main advantage of trading using opposite Cancer Genetics and Oppenheimer Ultra positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cancer Genetics position performs unexpectedly, Oppenheimer Ultra can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oppenheimer Ultra will offset losses from the drop in Oppenheimer Ultra's long position.
The idea behind Cancer Genetics and Oppenheimer Ultra Short Duration pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio